In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation unfolding in Malawi, East Africa. The Ministry of Health (“MOH”) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping sickness crisis affecting the region.

PaxMedica swiftly responded to this call for help by committing to provide emergency access to its recently completed registration batches of PAX-101, an IV form of suramin. This decision underscores PaxMedica’s dedication to mitigating the devastating impact of sleeping sickness and ensuring access to life-saving medications in regions facing critical shortages.

Howard Weisman, Chairman and CEO of PaxMedica, emphasized the urgent need for IV suramin in Malawi, stating, “The emergency request from the Ministry of Health of Malawi underscores the critical need for IV suramin to combat the continued devastating impact of sleeping sickness in the region.” PaxMedica’s proactive stance in responding to this crisis highlights the company’s commitment to addressing urgent healthcare needs and advancing treatments for neurological disorders on a global scale.

This recent development follows PaxMedica’s completion of three pivotal registration/validation batches of PAX-101, marking a significant milestone in the company’s ongoing development program. PaxMedica’s collaborative efforts with physicians and government bodies in Malawi and neighboring countries further demonstrate its commitment to advancing treatments for Trypanosoma brucei rhodesiense Human African trypanosomiasis (TBr HAT).

In light of these developments, PaxMedica is actively engaging with regulatory authorities in both the U.S. and Malawi to expedite its response to the urgent medical crisis. The company aims to navigate the regulatory landscape efficiently while ensuring a steady supply of suramin to address critical healthcare needs in endemic regions.

As the global community grapples with the challenges posed by infectious diseases, PaxMedica’s swift and decisive response to the urgent crisis in Malawi highlights the critical role of biopharmaceutical companies in addressing public health emergencies and advancing global healthcare initiatives.

For more information, visit the company’s website at www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

McEwen Mining (NYSE: MUX) (TSX: MUX) has been a standout performer in the Basic Materials sector this year, showcasing a remarkable growth trajectory that has caught the attention of investors and analysts alike. With a year-to-date stock price increase of approximately 51%, MUX has significantly outpaced the average performance of its sector peers, which have seen an average decline of about 2.7%. This impressive growth is not just a number but a testament to the company’s resilience and potential for future gains.

The surge in MUX’s stock price is further bolstered by a substantial upward revision in earnings estimates. Over the past quarter, the Zacks Consensus Estimate for MUX’s full-year earnings has jumped by 67.7%, painting a picture of a company on the rise. This optimistic outlook is reflected in its Zacks Rank of #1 (Strong Buy), signaling strong confidence in its ability to outperform in the near term. Such a significant revision in earnings estimates is a clear indicator of the company’s robust financial health and the positive sentiment surrounding its growth prospects.

In the broader context of the Basic Materials sector, MUX’s performance is even more remarkable when compared to its industry peers. Within the Mining – Miscellaneous industry, which includes 60 individual stocks, the average year-to-date return has been -8.1%. This stark contrast highlights MUX’s exceptional performance and sets it apart as a leader in its field. Meanwhile, another player in the sector, New Found Gold Corp. (NFGC), has also seen positive movement but to a lesser extent, with a year-to-date return of 3.7% and a modest increase in its consensus EPS estimate.

The recent trading activity of MUX further underscores its strong market position. The stock has seen fluctuations between $10.57 and $11.15 during a trading day, eventually closing at $11.03, which represents a 1.47% increase. This movement is part of a broader trend that has seen MUX’s stock price range from $5.92 to $12.23 over the past year. With a market capitalization of approximately $523.84 million and a trading volume of 527,299 shares, MUX’s financial metrics reflect a company that is not only growing but also attracting significant investor interest.

For investors eyeing opportunities within the Basic Materials sector, McEwen Mining presents a compelling case. Its standout performance, backed by a strong upward revision in earnings estimates and a robust market position, makes it a noteworthy option for those looking to capitalize on the sector’s potential. As MUX continues to outperform its peers and industry averages, it remains a key player to watch in the evolving landscape of the Basic Materials sector.

For more information, visit the company’s website at www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

• Mineral exploration and mining company Tartisan Nickel Corp. recently engaged Northwest Solutions Inc. (“NWS”) to provide project management and other support for its flagship Kenbridge Nickel Project in Ontario
• NWS Inc. offers a range of services, including forestry, mining,222a4444 and environmental services, as well as training, project management support, and communications consulting services
• Kevin Shorthouse, NWS, has been named Road Design and Road Permitting Project Manager
• Brandi Shorthouse, NWS, will be the Finance and Communications Manager for the Kenbridge Road Project
• Greg Edwards (Tartisan), current Project Manager for the Kenbridge Nickel Project, has been named the Company’s First Nations Liaison

Tartisan Nickel (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA), a Canadian mineral and battery metals exploration and mining development company, has recently engaged Northwest Solutions Inc. (“NWS”), an organization based in Thunder Bay, Ontario, to provide technical and human resource support for its flagship Kenbridge Nickel Project situated in the Kenora Mining District, northwestern Ontario. NWS Inc. offers a range of services, including forestry, mining, and environmental services, as well as training, project management support, and communications consulting services (https://ibn.fm/zQoZz).

NWS, family-owned and operated, has long been active in the Forestry and Natural Resource Sector, and will leverage cutting-edge technologies like LiDAR, RoadEng, and ArcGIS Pro, to provide road design, permitting, and project management support for the Kenbridge Nickel Project.

Kevin Shorthouse, MScF, R.P.F., a co-owner and Director of Northwest Solutions Inc., will serve as the Road Design and Road Permitting Project Manager for Tartisan Nickel Corp.’s Kenbridge Nickel Project. With over two decades of experience in Canada’s Natural Resources Sector, Kevin brings a unique combination of field experience, project management skills, and technological expertise to the table.

He will collaborate with forestry and mining companies, Indigenous communities, and landowners to find cost-effective solutions for the all-season road, employing advanced technologies such as LiDAR, multispectral imagery, AI analytics, and drones. Kevin will also engage with Indigenous and local community members to integrate traditional spaces of spiritual and historical significance into the project, potentially offering FireSmart and natural resources technical training to contribute to capacity building and land management practices.

Brandi Shorthouse, MA, the Administration and Finance Manager and co-owner of Northwest Solutions Inc., is also joining the team. Brandi will be the Finance and Communications Manager for the Kenbridge Road Project, overseeing budget administration, which includes supplies, contractors, staffing, and government grants.

With over a decade of experience in business finance and administration, Brandi’s upbringing in Northern Ontario and her close ties to the Anishinaabe people inform her approach, emphasizing relational business practices and reconciliation. She will support Tartisan Nickel Corp. in engaging with local Indigenous communities during consultation, ensuring transparent communication, respecting cultural protocols, and promoting accountability and sound governance.

Additionally, Tartisan Nickel Corp. is pleased to appoint Gregory (Greg) Edwards, B.Sc., Geo. Eng., who is currently serving as Project Manager for the Kenbridge Nickel Project and as the Company’s First Nations Liaison. Greg, a graduate of The Montana Tech School of Mines, brings over 18 years of experience in mining and exploration to the role, with expertise in geological engineering, mining engineering, and exploration techniques.

He will work closely with Indigenous community leaders, elders, and councils to address concerns and identify opportunities for economic development, capacity building, and job creation within First Nations communities. Greg is committed to ethical and sustainable practices, ensuring that exploration and mining activities minimize environmental impact and respect Indigenous rights and cultural heritage.

Tartisan aims to develop a more comprehensive and culturally sensitive approach to resource extraction by integrating traditional knowledge and Indigenous perspectives into decision-making processes.

“2024 promises to be a milestone year as multiple ongoing initiatives come together. Alignment with Indigenous communities, summation of baseline studies, project permitting endeavors, and all-season road access combined with continued efforts to expand the Kenbridge mine life are in focus and should prove to have a profound impact on shareholder value,” said Mark Appleby, CEO of Tartisan.

For more information, visit the company’s website at www.TartisanNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to TTSRF are available in the company’s newsroom at https://ibn.fm/TTSRF

• Bebuzee’s superapp combines the best of social networking, streaming, and informational resources seamlessly integrated into one dynamic interface
• The global superapp market was valued at $61.30 billion in 2022 and is expected to reach $718 billion by 2032, growing at a CAGR of 27.9%
• Bebuzee is committed to user privacy and security, underscoring its unwavering dedication to providing a safe and enjoyable online environment for all
• Bebuzee’s superapp provides relevant news, video, and digital entertainment that is localized to the user’s location

Bebuzee (OTC: BBUZ), formerly known as Engage Mobility Inc., proudly announces the development of its revolutionary superapp, set to redefine social engagement and streaming services across Western markets. With a focus on innovation and user-centric design, Bebuzee introduces an all-encompassing platform that combines the best of social networking, streaming, and informational resources seamlessly integrated into one dynamic interface.

The Bebuzee Superapp is engineered to cater to its members’ diverse interests and needs, offering a myriad of features designed to enhance their digital experience. From video streaming to photo sharing, from messaging services to real estate searches, Bebuzee is a one-stop destination for entertainment, communication, and information consumption. With a user-friendly interface and cutting-edge technology, Bebuzee empowers users to access a wide variety of content on any internet-connected device, making it the ultimate companion for the modern digital lifestyle.

The global superapp market was valued at $61.30 billion in 2022 and is expected to reach $718 billion by 2032, growing at a CAGR of 27.9%. The market’s growth is attributed to the ability to multi-task and complete several actions in one app. The rising number of people worldwide using smartphones also facilitates the superapp market’s growth (https://ibn.fm/m6MWa).

Bebuzee’s dedication to delivering relevant, localized content sets it apart in an increasingly crowded digital landscape. By curating news, blogs, videos, and photos from around the world, Bebuzee ensures that its users stay informed and entertained, no matter where they are. Bebuzee’s commitment to user privacy and security underscores its unwavering dedication to providing a safe and enjoyable online environment for all.

Bebuzee’s superapp offers:

• Video sharing
• Photo sharing
• Bebuzee Messaging service (text and voice messages, voice and video calls)
• Shortbuz (short-form entertaining videos)
• Blogbuz (news and information resource)
• Properbuz (global real estate search)
• Global tradesmen search
• Location reviews (neighborhoods, cities, regions)
• ShoppingBuz (technology-driven e-commerce platform)
• Bebuzee Pay (mobile payment and digital wallet service)
• TravelBuz (online travel booking service)
• EventBuz (ticket exchange and resale platform)
• FlightBuz (flight search engine)

While still developing, the superapp promises a growing revolution in how users access and interact with content, offering a seamless experience across any internet-connected device. From streaming movies, series, documentaries, and talk shows to providing curated news and features from around the globe, Bebuzee’s innovative technology consolidates the best of the internet into a single, integrated platform. With its imminent transition to a more polished version in the coming months, Bebuzee aims to redefine the digital landscape by offering users unparalleled convenience and access to diverse content.

The company’s headquarters in Miami serves as the center of its operations, reflecting its vibrant and diverse community. As Bebuzee continues to expand its reach and influence, it remains committed to serving the needs of its users and driving innovation in the digital sphere.

For more information, visit the company’s website at www.Bebuzee.com.

NOTE TO INVESTORS: The latest news and updates relating to BBUZ are available in the company’s newsroom at https://ibn.fm/BBUZ

• The cannabis industry supports communities through job creation, tax revenue generation, social equity programs, and community outreach initiatives
• ZDPY focuses on seizing direct-to-consumer real estate opportunities in the regulated cannabis market while enabling businesses to support the communities where they operate
• ZDPY’s portfolio includes properties leased to licensed cannabis operators in Arizona, Illinois, and Michigan with 100% occupancy and a weighted average lease term of 10+ years
• ZDPY anticipates more than $2.5 million from its property investment portfolio in 2024

The cannabis industry supports the community through job creation, tax revenue generation for essential services, social equity programs, philanthropic efforts, and community outreach initiatives. Additionally, it stimulates economic growth by attracting investment and revitalizing properties, ultimately contributing to community development and enhanced infrastructure.

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company, focuses on acquiring direct-to-consumer real estate opportunities in the regulated cannabis market while enabling businesses to support the communities they serve.

By investing in cannabis real estate projects and operating commercial properties leased to licensed cannabis operators, ZDPY indirectly contributes to job creation in its target areas. Further, ZDPY’s real estate development projects potentially lead to the revitalization of underutilized properties and the enhancement of local neighborhoods. By transforming properties to meet the needs of cannabis businesses, ZDPY potentially contributes to the overall improvement of community infrastructure and aesthetics.

ZDPY’s portfolio includes properties leased to licensed cannabis operators in Arizona, Illinois, and Michigan. Each project has 100% occupancy and a weighted average lease term of 10+ years, leading to estimates of more than $2.5 million in revenue for 2024.

Michigan has emerged as an example where the cannabis industry has made significant strides in community revitalization efforts. In 2023, the sector generated $87.1 million in excise tax revenue, leading to tangible improvements in public infrastructure (https://ibn.fm/9Dm8d).

Municipalities are leveraging these funds for street enhancements and park rejuvenation projects, fueled by licensing fees that reflect the industry’s growth. “This period marks an unparalleled level of street advancement in half a century,” said Mike Burns, City Manager at Lowell, Michigan. With foliage not the only thing going green, the cannabis excise tax is hailed as a key contributor to this urban metamorphosis.”

Besides contributing to local infrastructure, many states have also integrated social equity programs within their cannabis regulations to address the historical injustices of the War on Drugs. With a focus on promoting diversity and inclusion, these programs provide support and resources to individuals from communities disproportionately affected by cannabis prohibition.

Social advocates can look forward to more progress as the industry expands. According to MJBizDaily, total sales of medical and recreational cannabis in the United States reached approximately $33.6 billion by year-end 2023 (https://ibn.fm/ZjwXP). Further estimates by the research group reveal that combined retail cannabis sales in the U.S. are poised to surpass $53.5 billion by year-end 2027, leading to unprecedented opportunities for real estate companies like ZDPY.

Based in Arizona, Zoned Properties is led by Chairman and CEO Bryan McLaren, whose expertise in sustainable community and real estate development spearheads the company’s unique strategy. As the cannabis industry continues to grow, ZDPY is strongly positioned to seize real estate prospects within the swiftly expanding retail cannabis market.

For more information, visit the company’s website at www.ZonedProperties.com.

NOTE TO INVESTORS: The latest news and updates relating to ZDPY are available in the company’s newsroom at https://ibn.fm/ZDPY

• Transitioning from fossil fuel dependence to alternative, renewable energy sources has taken on increasing importance amid concerns about the growing consequences of climate change
• Federal government incentives and experimental projects are helping to drive efforts to transition the United States to greater renewable energy use from carbon-based energy sources
• Idaho-based Correlate Energy Corp. is a distributed energy solutions company making the transition to renewable energy more accessible to mid-tier companies, particularly those with nationwide portfolios that may create multiple revenue opportunities
• With proven user-friendly finance models, the company works to strategically develop, and profitably sell microgrids and localized green energy solutions, with plans to ultimately retain ownership of some of its energy systems to provide sustainable revenues

Nearly 70 percent of American adults want renewable energy sources such as wind, solar and hydrogen power to be granted developmental policy priority over fossil fuels, according to a Pew Research report last year (https://ibn.fm/ZQmJD), but renewable energy development remains a politically polarizing concern (https://ibn.fm/qShmx).

Texas, the second-largest state by geography and by population, surpassing 30 million residents in 2022 (https://ibn.fm/1rfyY), has recently reversed decades of support for renewable energy that led it to become the nation’s largest wind power producer, turning instead to fossil fuel support in a variety of government proposals (https://ibn.fm/VNrnU).

Although Texas is the largest consumer of coal power in the United States, renewable energy innovation persists in the state, highlighted perhaps by a U.S. Department of Energy experimental foray into a concentrating solar energy project that relies on using supercritical carbon dioxide to work turbines, instead of steam.

The project has the potential to eliminate concerns about the variability of wind and solar power generation, making solar power able to “pump out electricity or industrial process heat on a 24/7 basis, no matter what the sun is doing,” (https://ibn.fm/5fYYY).

Success for the government initiative could be a new shot in the arm for groups pushing the adoption of renewable energy to combat the anticipated ravages of climate change. Distributed energy solutions company Correlate Energy (OTCQB: CIPI) is a company helping to promote that adoption at a corporate level for mid-tier companies that are often overlooked by large energy companies and consulting firms in the sustainability market.

Correlate Energy’s efforts include identifying localized clean energy solutions and microgrids that the company can finance, develop, and profitably sell to its clientele. Its strategy for scale includes becoming capable of retaining ownership of some of its energy systems to provide sustainable revenues.

To date, the company has completed a number of significant solar energy projects throughout the country, such as an 8.2 MW rooftop solar energy project atop the MGM Mandalay Resort in Las Vegas, a 12.9 MW system for Arizona State University that provides 71 percent of campus solar output, a 6.48 MW project for NFL stadiums in California, New York, Washington and Massachusetts, and a 4.5 MW system for Albertsons-Safeway stores in California.

Correlate participated in a Xendee webinar last month in which company executives discussed their work with Xendee’s PROPOSE distributed energy resource platform to expedite the site analysis process and design proposals that win more deals and inspire investor confidence.

“Behind the meter solar … has been our focus for a long time, specifically on large commercial and industrial properties,” Correlate’s Solar Energy & Storage Director Jason Loyet said during the webcast (https://ibn.fm/0nzEX), showcasing a 908-kW solar project recently commissioned and successfully built in Illinois as part of the national portfolios new clients bring in. “We’re at a unique opportunity in the industry, that we really need to move through the design and really qualify the projects and the technologies around it and understand (if this is) a viable project.”

“That continuous evolution from propose to design and to operate I think is really important for customers to feel confident that they’re going to get the results that you’re presenting to them and for you internally to have confidence that you’re not going to get hung out to dry by presenting something to a client and then having to back-walk it because your real design is coming up with different answers,” Chief Product Officer Leif Elgethun said. “I think (the PROPOSE platform) runs hundreds or thousands of different scenarios to come up with the best possible way of designing the system from a sizing standpoint, but then also how are you going to dispatch it if it includes solar storage, EVs (electric vehicles) and other assets, so like literally down to the hour.”

The tool provides Correlate a powerful resource for moving the project rapidly through to completion. 

For more information, visit the company’s website at www.Correlate.Energy, including the following:

Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.Correlate.Energy/our-process
Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.Correlate.Energy/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Fentanyl is a potent opioid that is associated with a significant risk of abuse and overdose, contributing to a major drug crisis in the United States
• Fentanyl has legitimate medical uses in managing severe and chronic pain in medical settings such as hospitals and surgical procedures
• NTRB is advancing its AVERSA(TM) technology that incorporates aversive agents to prevent abuse, diversion, misuse, and accidental exposure to opioids and other drugs with abuse potential
• NTRB was recently granted a patent for AVERSA(TM), strengthening its intellectual property portfolio in the United States and globally across 45 countries

Fentanyl, a potent opioid, poses a significant problem due to its potential for abuse with a high risk of overdose – even in small quantities. Nutriband (NASDAQ: NTRB) is advancing its AVERSA(TM) technology that features aversive agents to prevent abuse, diversion, misuse, and accidental exposure to drugs with abuse potential, specifically opioids.

“AVERSA is a platform technology that can be deployed in almost any transdermal product that carries a risk of abuse or misuse. It is our mission to reduce the risk profile of these drugs while ensuring availability for patients that need them,” said NTRB CEO Gareth Sheridan in recent statements (https://ibn.fm/C1Xiq).

The abuse of fentanyl is contributing to the worst drug crisis in the history of the United States. According to the Council on Foreign Relations, more than a million people in the United States have died of drug overdoses since 2000, and the majority of these cases were due to opioids with fentanyl being the leading cause (https://ibn.fm/y2vfV). In the last two years alone, overdose rates have been approximately 112,000 and 108,000 respectively.

Despite its potential for abuse, fentanyl has legitimate medical uses when prescribed and administered properly to treat chronic pain. Used commonly in medical settings, the drug effectively manages post-operative pain, cancer-related pain, and pain associated with severe injuries. Additionally, it is sometimes used as anesthesia during surgical procedures due to its fast-acting and short-duration properties.

NTRB is facilitating the responsible use of fentanyl through its AVERSA(TM) technology. AVERSA(TM) works by incorporating aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. By incorporating these aversive agents onto the backing of the patch, AVERSA(TM) aims to deter individuals from tampering with or abusing the medication while ensuring the medication remains accessible to patients who genuinely need it for pain management.  The Company is partnered with Kindeva Drug Delivery, utilizing Kindeva’s FDA approved Fentanyl patch and adding Nutriband’s AVERSA technology.  The Company aims to file for FDA marketing approval in 2025.

Nutriband recently announced the issuance of a new U.S. patent No. 11,759,431 for its AVERSA(TM) abuse deterrent technology by the United States Patent and Trademark Office (https://ibn.fm/tnWXi). This patent expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products.

“The issuance of this patent covering our AVERSA(TM) abuse deterrent transdermal technology that utilizes taste aversion to address a primary route of abuse of opioid patches is an important component of our global IP portfolio,” said CEO Gareth Sheridan.

“This new patent strengthens our intellectual property position, which includes patents issued in 45 countries around the world.”

Nutriband Inc. primarily engages in developing its portfolio of transdermal pharmaceutical products. Led by an experienced management team with extensive experience in the pharmaceutical sector, the company is dedicated to its mission of enhancing the safety, efficacy, and responsible use of pharmaceutical treatments for patients worldwide.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• Developments in Australia’s efforts to limit youth offender recidivism underscore the importance of being able to track select probationary participants
• Israel-based SuperCom Ltd. is positioning itself to be a world leader in providing court-administered offender tracking, which may include youths potentially prone to recidivism
• The company is growing on a global scale with contracts in Romania, Finland, Croatia, Sweden, and various states in the United States, in a marketplace with an anticipated 9.5 percent CAGR over the next five years

An Australian court’s decision to have young criminal suspects wear electronic ankle bracelet monitors is helping law enforcement advocates successfully deal with concerns about violent recidivism while court proceedings are in progress, while also allowing teen suspects to enjoy a measure of freedom while under court supervision (https://ibn.fm/gWthl).

Legal authorities affirm in the report that the technology is a sensible way of allowing suspected teen offenders to continue their normal daily activities within the parameters of court-ordered restrictions while minimizing the prospects of unlawful behaviors.

The need for such restrictions was underscored by the recent widely publicized “terrorist” stabbing attack on congregants at a Sydney church, in which a teen suspect was identified as a recently arrested knife crime offender who was freed on a good behavior bond (https://ibn.fm/6cWYI).

Electronic-monitoring (“EM”) security solutions developer SuperCom (NASDAQ: SPCB) is building clientele among government agencies worldwide to improve public safety while also limiting the stigma that teen advocates worry about in regard to wearing the monitoring bracelets.

SuperCom’s PureSecurity Suite combines its EM technology platform with EM-related services administered by SuperCom subsidiary Leaders in Community Alternatives (“LCA”) to provide an efficient and reliable, but discrete, set of cutting-edge tools for tracking offenders.

The company is rolling out its services on a global scale, with the majority of its projects widely spread across Europe and the United States.

SuperCom’s monitors are easily concealable to reduce concerns about unnecessary stigmatizing of youthful wearers, a concern in the community. The product suite’s artificial intelligence (“AI”) adoption delivers powerful ability for optimal decision-making through effective data analysis, predictive modeling, and streamlined operation.

Its ultra-lightweight base station, long battery life and onboard GPS tracking with field-proven RFID, are appealing for mobile operation. 

Market potential for the court-administered electronic monitoring sector is expected to reach $2.3 billion by 2029 at a 9.5 percent CAGR (https://ibn.fm/rvZPx), highlighting the value of SuperCom’s efforts to position itself at the front of its sector.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• EAWD is a green-tech engineering solutions company that builds water and energy systems for clients, including private companies, government entities and NGOs
• The company has sold and deployed its water systems in Mexico and Germany
• Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany
• In December 2023, the company announced a joint Memorandum of Understanding to build the first off-grid atmosphere water generation plant in North America

Energy and Water Development (OTCQB: EAWD) is a green-tech engineering solutions company focused on delivering water and energy to extreme environments. The company builds water and energy systems out of already existing, proven technologies, utilizing its patent-pending systems configuration and technical know-how to customize solutions to meet clients’ needs. To date, two water systems have been sold and deployed in Mexico and Germany, and the company is working to fulfill additional orders.

Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany. The company is a United Nations-accredited vendor and offers design, construction, maintenance and specialty consulting services to private companies, government entities and non-government organizations for the sustainable supply of energy and water.

EAWD focuses on three main aspects of the water and energy business: (1) generation, (2) supply and (3) maintenance. The green tech industry is constantly evolving due to ongoing and increasing water scarcity, as well as increased energy needs in the world. Therefore, the company believes that by designing sustainable and renewable solutions to these problems, EAWD will become an essential component of a rapidly growing industry with many new markets.

EAWD’s approach seeks to assist businesses with the growth and development of their general operations by ensuring the efficient, profitable and sustainable supply and generation of water and energy, allowing its potential customers to focus on their business while adopting strategies of sustainability.

By using the state-of-the-art technological solutions and technologies identified, designed and provided by EAWD and its collaborators, the company believes that its potential clients will be free to focus on the performance of their operations, as well as with the water and energy consumption or generation regulations within their industries.

EAWD is headquartered in Saint Petersburg, Florida, with operations in Germany and Mexico.

Products

In view of the increased worldwide demand for water and energy, EAWD’s business goals are focused on self-sufficient energy-supplied water generation and green energy production. To accomplish this, the company set out to establish an outsourcing green tech platform to commercialize its state-of-the-art technologies while providing engineering and technical consultation services to design the most sustainable technological solutions that can provide water and energy.

The company has sought potential collaboration with green tech research and development centers in Europe and has established its operating subsidiaries in Hamburg, Germany, where EAWD has started to assemble its patent-pending innovative off-grid, self-sufficient energy supply atmosphere water generation (“AWG”) systems.

EAWD Deutschland and EAWD Logistik operate in Hamburg, Germany, to meet the increasing demands of water and energy generation projects around the world, as well as to operate the solar-powered EAWD Off-Grid EV Charging Stations, EAWD’s newest product.

The company expects to offer sustainable added value to each project it takes on, while generating revenue from the sale of EAWD Off-Grid AWG Systems, EAWD Off-Grid EV Charging Stations, EAWD Off-Grid Power Systems and EAWD Off-Grid Water Purification Systems; royalties from the commercialization of energy and water in certain cases; and licensing of its innovated technologies, along with its engineering, technical consulting and project management services.

EAWD continues to be a development stage company. It presently assembles its EAWD Off-Grid AWG Systems and EAWD Off-Grid EV Charging Stations at its workshop in Germany and outsources most of its engineering and technical services, as well as services relating to the promotion, sale and distribution of its products.

Market Opportunity

According to a report by Allied Market Research, a global market research, consulting and advisory firm, the worldwide green technology and sustainability market was valued at $10.32 billion in 2020 and is projected to reach a value of $74.64 billion by 2030, growing at a CAGR of 21.9% during the forecast period.

A surge in environmental awareness and increasing concerns among organizations and individuals about climate change drive the growth of the market. Furthermore, an increase in consumer and industrial interest for the use of clean energy resources are among some of the major factors expected to boost growth of the market in the coming years, according to the report.

The expected rise in favorable government and private initiatives to tackle climate change and air pollution represent an opportunistic factor of the market. An increase in energy consumption and rise in greenhouse gas emissions are major factors that drive the development of green technology innovations, the report states.

Management Team

Irma Velazquez is CEO and Vice Chair at EAWD. She brings certified expertise in sustainable development and large-scale project management to the company. She formerly worked for United Nations agencies including the World Health Organization, Farmaciens Sans Frontieres, Red Cross and Crescent Societies, where she served in the positions of Information Technology Manager, Sustainable Development Manager, Programme Manager and Disaster and Crisis Management Coordinator. She has a master’s in sciences from the Erasmus University of Rotterdam. She speaks French, English and Spanish.

Ralph Hofmeier is Chief Technology Officer and Chairman at EAWD. He brings a mechanical engineering background to the company and previously served as President of Powermax Energy & Business Solutions Inc. When that company merged with EAWD, he served as President and CEO of Directors of EAWD. Over the last 20 years, he has established and developed several multinational companies in green tech distribution and commercialization. He speaks German and English.

For more information, visit the company’s website at www.Energy-Water.com.

NOTE TO INVESTORS: The latest news and updates relating to EAWD are available in the company’s newsroom at http://ibn.fm/EAWD

• CNM-Au8 is an oral suspension with demonstrated activity in restoring neuronal health and function by increasing energy production and utilization
• Treatment with CNM-Au8 investigated in clinical trials adjunctive to standard-of-care exhibits no known drug interactions, and aims to enhance function and survival
• Nearly 90,000 people are diagnosed with Parkinson’s disease every year with no approved drug to slow or halt disease progression currently available
• The Parkinson’s disease treatment market was valued at $4.61 billion in 2022 and is expected to reach $11.98 billion by 2030

In recognition of April as Parkinson’s Disease Awareness Month, IBN is highlighting Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including Parkinson’s disease (“PD”), amyotrophic lateral sclerosis (“ALS”), and multiple sclerosis (“MS”). Clene is developing its lead drug candidate CNM-Au8(R) for potential treatment of these neurodegenerative diseases. CNM-Au8 is an oral suspension designed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy-producing reactions that enable neuroprotection and remyelination. The result is an increase in neuronal and glial resilience to disease-relevant stressors.

In March 2021, Clene was awarded a grant from The Michael J Fox Foundation for Parkinson’s Research (“MJFF”) to accelerate the development of CNM-Au8 as a treatment for PD. The funding supports efficacy studies in a human cell culture model of PD that utilizes skin cells from individuals with PD. The cells are then converted in the laboratory to dopaminergic neurons that exhibit many aspects of the disease state. The research, led by Karen Ho, PhD, VP Translational Medicine at Clene, was a collaboration with Dr. Jerome Mertens while he was Assistant Professor at the University of Innsbruck (currently Associate Professor in the Department of Neurosciences of the University of California, San Diego) and is currently a collaboration with Dr. Fred (“Rusty”) Gage, Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease, Professor of Genetics of the Salk Institute. These two scientists are world-renowned researchers who pioneered the specific techniques to generate the human cell model utilized for the project. The team is exploring multiple aspects of the effects of CNM-Au8 on PD neurons, including potential improvements in mitochondrial function and effects on transcriptomic profiles in comparison to untreated healthy and disease controls. Results from the study are expected in Q2 2024.

The peer-reviewed publication, “Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials,” was published in Journal of Nanobiotechnology in December 2023 (https://link.springer.com/article/10.1186/s12951-023-02236-z). The study demonstrated that oral daily doses of CNM-Au8 over 12 weeks leads to increased levels of brain metabolites associated with improved mitochondrial function and brain health in these diseases.

Over 600 cumulative years of CNM-Au8 patient exposure across ALS, MS, and PD trials and compassionate use programs have shown no safety concerns. With safety, early efficacy, and brain target engagement data in hand for PD, Clene is advancing CNM-Au8’s development as a potential first-in-class treatment for PD.

A Parkinson’s Foundation-backed study in 2022 found that nearly 90,000 people are diagnosed with Parkinson’s disease every year – which is approximately the amount of fans at the Rose Bowl Stadium. This number represents a 50% increase from the previous estimated rate of 60,000 diagnoses annually.

“These updated estimates of incidence are necessary for understanding disease risk, planning health care delivery, and addressing care disparities,” said James Beck, Ph.D., Parkinson’s Foundation Chief Scientific Officer (https://ibn.fm/0xzdX). “Knowing this information will allow us to better serve people with Parkinson’s and their families and plan for adequate health care services in the future.”

The Parkinson’s disease treatment market was valued at $4.61 billion in 2022. It is expected to grow at a CAGR of 12.1%, resulting in an estimated value of $11.98 billion by 2030. The market’s growth is supported by the increasing geriatric population, the high burden of Parkinson’s disease in Western countries, and the strong product pipeline of disease-modifying therapies. It is estimated that Parkinson’s disease affects around 1% of the total population aged 60 years and older and rises to 5% for 85 years and older (https://ibn.fm/3ySss).

CNM-Au8(R) is a federally registered trademark of Clene Nanomedicine, Inc.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN